News
AstraZeneca (LSE:AZN) Launches FluMist Home For At-Home Influenza Vaccination
AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important milestone for easier access to vaccinations in 34 U.S. states. This initiative likely contributed to its stock price increase of 12% last quarter,
AstraZeneca has launched FluMist Home, a nasal spray flu vaccine with at-home delivery service. For those who have a needle ...
FLUMIST, AstraZeneca’s FDA-approved flu nasal vaccine, can now be ordered and used at home with zero needles or clinic hassle ...
FluMist is the only nasal vaccine approved in the U.S. It’s administered as two spritzes—one in each nostril—and stimulates ...
AstraZeneca's FluMist, which has the Food and Drug Administration approval, can now be home-delivered to people in 34 states ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback